| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |